Skip to main content


Icon Legend
This session is not in your favorites.
This session is in your favorites. Click again to remove it.
Presentation Icons
Live Stream Sessions
Live Stream Sessions

Assessor Recommended Sessions

Assessor Recommended Sessions

  • Saturday, Oct 19th
    8:15 AM - 9:15 AM  
    AM24-ST-01-L - The Use of HLA-Typed Cellular Transfusions and/or Infusions for In Vivo Adsorption of Donor-Specific HLA Antibodies (DSAs) as a Desensitization Strategy for Hematopoietic Stem Cell Transplant Patients
    Location: 320
    Speaker: Deanna C. Fang, MD – UC San Diego School of Medicine
    Speaker: Stefan Ciurea, MD – UNIVERSITY OF CALIFORNIA, IRVINE
    Program Chair: Minh-Ha Tran, DO – AABB Member
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Saturday, Oct 19th
    9:45 AM - 10:45 AM  
    AM24-ST-09-L - Sterility Testing for Cellular Therapies: Updates and Challenges.  What should we be doing?
    Location: 320
    Program Chair: J. Wade Atkins, MS, MLS, SBB, CQA, CABP(H) – NIH/CC/DTM
    Speaker: Elizabeth Lessey-Morillon, PhD, RAC (she/her/hers) – Center for Biologics Evaluation and Research; Office of Therapeutic Products; Office of Cellular Therapy & Human Tissue CMC; U.S. Food and Drug Administration
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Saturday, Oct 19th
    9:45 AM - 10:45 AM  
    OA2-AM24-ST-13 - In Vitro Quality of RBCs in PAGGS-M Prepared in Non-DEHP Bag Systems: Influence of Weekly Mixing
    Location: 342
    Presenting Author: Ute Gravemann, PhD (she/her/hers) – German Red Cross Blood Service NSTOB
    Quality
     CE: Zero
  • Saturday, Oct 19th
    9:45 AM - 10:45 AM  
    OA4-AM24-ST-13 - Residual Red Blood Cells (rRBC) and Microparticles (MP) in Apheresis Platelet Products
    Location: 342
    Presenting Author: Susanne Marschner (she/her/hers) – Vitalant Research Institute
    Blood Center/Blood Hospital-Based Donor Center
     CE: Zero
  • Saturday, Oct 19th
    11:15 AM - 12:15 PM  
    AM24-ST-15-L - Sickle Cell Disease Psychosocial Support and Advocacy
    Location: 320
    Program Chair: Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center
    Speaker: Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center
    Speaker: Adrienne Shapiro (she/her/hers) – Axis Advocacy
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Saturday, Oct 19th
    11:15 AM - 12:15 PM  
    AM24-ST-20-L - Enhancing Laboratory Competency with AI: Meeting AABB Standards for Cell Processing Facilities and Blood Banks
    Location: Grand Ballroom B
    Program Chair: WANXING CUI, PhD – MedStar Georgetown University Hospital
    Speaker: Daisy Annette, MLS (ASCP) SBB – Our Blood Institute
    Speaker: Jyotiska Biswas – ThinkTrends
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Saturday, Oct 19th
    1:45 PM - 2:45 PM  
    AM24-ST-21-L - Critical Role of an Assay Lifecycle in Analytical Development for Cell and Gene Therapy Products
    Location: 320
    Program Chair: Scott Jones, PhD (he/him/his) – BioBridge Global
    Speaker: Scott Jones, PhD (he/him/his) – BioBridge Global
    Speaker: Brent Morse, MS – Dark Horse Consulting Group
    Speaker: Emmanuel Casasola (he/him/his) – BioBridge Global
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    8:15 AM - 9:15 AM  
    AM24-SN-01-L - The Future of Cellular Therapy Using Mesenchymal Stromal Cells and Dendritic Cells
    Location: 320
    Program Chair: Wen Lu, MD – Mayo Clinic
    Speaker: Jacques Galipeau, MD – University of Wisconsin in Madison
    Speaker: Michael P. Gustafson, PhD – Mayo Clinic in Arizona
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    9:30 AM - 11:00 AM  
    PL2-SN-27 - ADAMTS13-Chimeric Auto-Antigen Receptor (CAAR) T cells To Target Autoreactive B cells As A Treatment For Immune-mediated Thrombotic Thrombocytopenic Purpura
    Presenting Author: Roman H. Khadka, PhD – University of Pennsylvania
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Sunday, Oct 20th
    9:30 AM - 11:00 AM  
    PL4-SN-27 - Freeze-Dried Platelets Decrease Bleeding in Refractory Thrombocytopenic Patients with Hematological Malignancies
    Presenting Author: Maro Ohanian, DO – MD Anderson Cancer Center
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Sunday, Oct 20th
    9:30 AM - 11:00 AM  
    PL5-SN-27 - Genetic Engineering of Megakaryocytes From Blood Progenitor Cells Using mRNA Lipid Nanoparticles
    Presenting Author: Jerry Leung, PhD (he/him/his) – University of British Columbia
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Sunday, Oct 20th
    2:00 PM - 3:00 PM  
    AM24-SN-09-L - Lesson's Learned Onboarding Cell and Gene Therapy Vendors and Clients in the 21st Century
    Location: Grand Ballroom B
    Program Chair: Kevin J. Land, MD – Vitalant
    Speaker: Melissa Marlowe, CHS, MBA – Vitalant
    Speaker: Kate Brown, PhD (she/they) – CooperSurgical, Inc.
    Speaker: Robert Marriott – Vitalant
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    2:00 PM - 3:00 PM  
    OA2-AM24-SN-15 - Frequency of Vasovagal Reactions with Large Volume Plasma Donations in Canada
    Location: 372
    Presenting Author: Aditi Khandelwal, MD MSc (she/her/hers) – Canadian Blood Services
    Blood Center/Blood Hospital-Based Donor Center
     CE: Zero
  • Sunday, Oct 20th
    3:30 PM - 5:00 PM  
    AM24-SN-17-L - Sickle Cell Disease: Inching towards Transfusion Independence. Exploring the Journey from Chronic Transfusions to the Novel Biotherapeutics
    Location: Grand Ballroom B
    Speaker: Ross Fasano, MD – Emory University
    Program Chair: Jeanne E. Hendrickson, MD – Emory University
    Speaker: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
    New Innovations, New Techniques and New Technologies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    3:30 PM - 5:00 PM  
    AM24-SN-19-L - Viral Vector Systems and Cellular Therapy
    Location: Grand Ballroom C
    Program Chair: Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company
    Speaker: Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company
    Speaker: Anderson Reuben, PE, LEED AP – Merrick
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    3:30 PM - 5:00 PM  
    AM24-SN-24-L - Crisis in the Rural Hospital Without Access to Blood Transfusion: Innovative Strategies to Address Global Blood Deserts and the Blood D.E.S.E.R.T. Coalition
    Location: 372
    Program Chair: LINDA S. Barnes, DrPH, MHA, RAC, CABP(H) (she/her/hers) – University of Pittsburgh
    Speaker: Nakul P. Raykar, MD MPH FACS (he/him/his) – Harvard Medical School
    Speaker: Asma Aliawadh, MBBS, MHM, MIPH (she/her/hers) – Langata and Kibera Sub-Counties, Kenya
    Speaker: Andrew Cap, MS, MD, PhD (he/him/his) – U.S. Army Institute of Surgical Research
    Speaker: Caroline Wesonga Wangamati, MSc MA (she/her/hers) – Coalition of Blood for Africa
    Speaker: Lucy Asamoah-Akuoko, MD MPH PHD – National Blood Service Ghana
    Public Health, Policy and Ethics
     CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    3:30 PM - 5:00 PM  
    AM24-SN-26-L - Transfusion Medicine, Hemostasis, Apheresis, and Cellular Therapy Review Session for Trainees
    Location: 342
    Speaker: Lance Williams, MD – Mayo Clinic
    Program Chair: Huy P. Pham, MD, MPH – NMDP
    Speaker: Huy P. Pham, MD, MPH – NMDP
    Speaker: David Oh, MD, MHA (he/him/his) – Hoxworth Blood Center
    Education/Developing Curriculum
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Sunday, Oct 20th
    3:30 PM - 5:00 PM  
    OA3-AM24-SN-23 - Novel Anticoagulant/Additive Solution Maintains the Hemostatic Function of Cold Stored Whole Blood for 56 Days
    Location: 362
    Presenting Author: Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
    Blood Center/Blood Hospital-Based Donor Center
     CE: Zero
  • Sunday, Oct 20th
    3:30 PM - 5:00 PM  
    OA4-AM24-SN-23 - Prolonged Storage of Leukoreduced Whole Blood Stored in CPD from 21 to 35 Days to Improve Prehospital Blood Supply Logistics
    Location: 362
    Presenting Author: Hanne Braathen, MSc (she/her/hers) – Haukeland University Hospital
    Quality
     CE: Zero
  • Monday, Oct 21st
    8:15 AM - 9:15 AM  
    AM24-MN-03-L - Clinical Relevance of ABO Antibodies and the New Era of Lectin Array Analysis of RBC ABO Glycosylation
    Location: Grand Ballroom C
    Speaker: Gregory A. Denomme, PhD (he/him/his) – Grifols Laboratory Solutions
    Speaker: Sean R. Stowell, MD PhD – Brigham and Women's Hospital
    Program Chair: Jian Chen, MD, PhD – Houston Methodist Hospital
    Immunohematology and Genetic Testing (red cells, leukocytes and platelets)
     CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Monday, Oct 21st
    9:45 AM - 10:45 AM  
    AM24-MN-09-L - Management of Hematotoxicity from Immune Effector Cell Therapy and Sickle Cell Disease Gene Therapy
    Location: 320
    Program Chair: Patricia Shi, MD (she/her/hers) – New York Blood Center
    Speaker: Alexis Leonard, MD (she/her/hers) – St. Jude Children's Research Hospital
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Monday, Oct 21st
    9:45 AM - 10:45 AM  
    OA2-AM24-MN-14 - Characterization of the Stored Platelet Unit Lipidome and its Relationship to Donor Sex and Hemostatic Function
    Location: 332
    Presenting Author: Jack Killinger, n/a – University of Pittsburgh
    Cell Biology, Immunology and Biochemistry (basic and preclinical research)
     CE: Zero
  • Monday, Oct 21st
    9:45 AM - 10:45 AM  
    OA3-AM24-MN-14 - Comparative Analysis of Room Temperature (RT) Day 7 and Cold Storage (CS) Day 21 Platelets: An Interim Evaluation of the Chilled Platelet Study in vitro (CHIPSiv)
    Location: 332
    Presenting Author: Irona Khandaker, MBBS, PhD – University of Pittsburgh
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Monday, Oct 21st
    9:45 AM - 10:45 AM  
    OA4-AM24-MN-14 - Impact Of P38 Mitogen Activated Protein Kinase And Minocycline On Platelets Stored At Cold Temperature For 21 Days
    Location: 332
    Presenting Author: Andrey Skripchenko, PhD (he/him/his) – FDA
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Monday, Oct 21st
    9:45 AM - 10:45 AM  
    OA1-AM24-MN-14 - Aggregates in Cold Stored Platelet Units have Diverse Phenotypes that are Removed by Transfusion Filters
    Location: 332
    Presenting Author: Kathleen Kelly, PhD – Vitalant Innovation Center
    Blood Center/Blood Hospital-Based Donor Center
     CE: Zero
  • Monday, Oct 21st
    9:45 AM - 10:45 AM  
    OA4-AM24-MN-15 - Incidence and Prevalence of Red Blood Cell Antibodies and Their Clinical Implications in Allogeneic Hematopoietic Stem Cell Transplantation: A BEST Collaborative Study
    Location: 362
    Presenting Author: Valery Kogler, MD – University of Virginia Health
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Monday, Oct 21st
    2:00 PM - 3:00 PM  
    AM24-MN-18-L - Mechanisms of Hematopoietic Stem Cells Towards Rejuvenation of the Aging Hematopoietic System
    Location: 320
    Program Chair: Ying Liang, PhD/MD (she/her/hers) – Lindsley F. Kimball Research Institute, NYBC
    Speaker: Katherine King, MD, PhD (she/her/hers) – Baylor College of Medicine
    Speaker: Marie-Dominique Filippi, PhD (she/her/hers) – Cincinnati Children's Hospital Research Foundation
    Cell Biology, Immunology and Biochemistry (basic and preclinical research)
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Monday, Oct 21st
    2:00 PM - 3:00 PM  
    OA1-AM24-MN-23 - HLA Alloimmunization in ReCePI, a Phase III Study of Amustaline/Glutathione Pathogen Reduced RBCs
    Location: 342
    Presenting Author: Philip Norris, MD – Vitalant Research Institute
    Cell Biology, Immunology and Biochemistry (basic and preclinical research)
     CE: Zero
  • Monday, Oct 21st
    3:30 PM - 5:00 PM  
    AM24-MN-26-L - Overview of Cell-Based Biologics Manufacturing as a Contracted Service
    Location: 320
    Program Chair: Christie Malone, MT(ASCP)SBB, CABP – GenCure
    Speaker: Lee Buckler, JD (he/him/his) – Blood Centers of America
    Speaker: Rogelio Zamilpa, PhD – GenCure
    Speaker: Sanjin Zvonic, PhD (he/him/his) – Dark Horse Consulting Group
    Speaker: Dominic Clarke, PhD – Cryoport Systems
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Monday, Oct 21st
    3:30 PM - 5:00 PM  
    AM24-MN-30-L - Solve It! Scenarios in Apheresis and Cellular Therapy
    Location: Grand Ballroom A
    Program Chair: Vasiliki E. Kalodimou, Professor Dr. CABP (H), IARMES (she/her/hers) – IASO Materbity & Research Hospital & EUC
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Monday, Oct 21st
    3:30 PM - 5:00 PM  
    AM24-MN-31-L - Cell Therapy: Creative Inventory Management & Discard
    Location: 342
    Program Chair: Brenda Alder, MS, MLS(ASCP)SBB, CABPH(AABB) (she/her/hers) – Northside Hospital Atlanta
    Speaker: Jennifer Westerman, MT(ASCP) (she/her/hers) – Northside Hospital Atlanta
    Speaker: Rupal Brahmbhatt, MLS (AMT), CABP (AABB) – Northside Hospital Atlanta
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Monday, Oct 21st
    3:30 PM - 5:00 PM  
    AM24-MN-32-L - Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think.
    Location: 362
    Program Chair: Claudia Cohn, MD, Phd – University of Minnesota
    Speaker: Anirban Sen Gupta, PhD (he/him/his) – Case Western Reserve University
    Speaker: Cedric Ghevaert, MD, PhD, FRCP, FRCPath (he/him/his) – University of Cambridge / NHS Blood and Transplant
    Speaker: Mike Fitzpatrick, PhD – Cellphire, Inc
    New Innovations, New Techniques and New Technologies
     CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Monday, Oct 21st
    5:30 PM - 6:30 PM  
    AM24-MN-34-L - Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation
    Location: 320
    Program Chair: Larry Luchsinger, PhD – New York Blood Center
    Speaker: Colleen Delaney, MD, MSc (she/her/hers) – Deverra Therapeutics
    Speaker: Adam Wilkinson, PhD (he/him/his) – University of Oxford
    Cell Biology, Immunology and Biochemistry (basic and preclinical research)
     CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Tuesday, Oct 22nd
    8:30 AM - 10:00 AM  
    AM24-TU-01-L - Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies
    Location: 320
    Program Chair: Indira Guleria, PhD, D(ABHI), CABP(H) – BIDMC and Harvard Medical School
    Speaker: Rafet Basar, MD – MD Anderson
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Tuesday, Oct 22nd
    8:30 AM - 10:00 AM  
    AM24-TU-03-L - Addressing Racial Disparities Across Donation Products for Marginalized Peoples
    Location: Grand Ballroom C
    Program Chair: Sylvia Okonofua, n/a – Black Donors Save Lives
    Speaker: Sylvia Okonofua, n/a – Black Donors Save Lives
    Speaker: Warren Fingrut, MD – University of Texas MD Anderson Cancer Center
    Public Health, Policy and Ethics
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Tuesday, Oct 22nd
    8:30 AM - 10:00 AM  
    OA2-AM24-TU-06 - Developing An Engineered T Cell Therapy To Eliminate Inhibitors In Hemophilia A
    Location: 342
    Presenting Author: Morgan Hresko, BS, MS – Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Tuesday, Oct 22nd
    8:30 AM - 10:00 AM  
    OA4-AM24-TU-06 - Rapid Isolation of CD4+ T Cells Using a Functionally Closed Microfluidic System for Generating Induced Regulatory T Cells for Adoptive Therapy
    Location: 342
    Presenting Author: Sergey S. Shevkoplyas, PhD – University of Houston
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: Zero
  • Tuesday, Oct 22nd
    10:30 AM - 11:30 AM  
    OA2-AM24-TU-14 - Microfluidic Leukapheresis is Safe and Effective in a Rat Model
    Location: 342
    Presenting Author: Sergey S. Shevkoplyas, PhD – University of Houston
    Therapeutic Apheresis
     CE: Zero